James Miller

3.2k total citations
28 papers, 573 citations indexed

About

James Miller is a scholar working on Epidemiology, Molecular Biology and Neurology. According to data from OpenAlex, James Miller has authored 28 papers receiving a total of 573 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 10 papers in Molecular Biology and 8 papers in Neurology. Recurrent topics in James Miller's work include Inflammatory Myopathies and Dermatomyositis (10 papers), Peripheral Neuropathies and Disorders (6 papers) and Muscle Physiology and Disorders (6 papers). James Miller is often cited by papers focused on Inflammatory Myopathies and Dermatomyositis (10 papers), Peripheral Neuropathies and Disorders (6 papers) and Muscle Physiology and Disorders (6 papers). James Miller collaborates with scholars based in United Kingdom, Australia and United States. James Miller's co-authors include Douglass M. Turnbull, Robert W. Taylor, Karolina A. Rygiel, John P. Grady, Patrick F. Chinnery, Mariana C. Rocha, Helen Griffin, Rita Horváth, Frank Mastaglia and Reimar Junckerstorff and has published in prestigious journals such as Nucleic Acids Research, Brain and Neurology.

In The Last Decade

James Miller

28 papers receiving 557 citations

Peers

James Miller

EPIDE

CMN

NEURO

GENET

Shiro Matsubara Japan

Kenya Murata Japan

Beate Schlotter Germany

Snjólaug Arnardottir Sweden

Andrew Engel United States

Jun Tsugawa Japan

Adolf Pou Spain

Nizar Chahin United States

Ingela Loell Sweden

Agata Polizzi Italy

Shiro Matsubara Japan

James Miller

263 ×1.1

201 ×0.8

EPIDE

110 ×0.7

CMN

239 ×1.9

NEURO

99 ×0.9

GENET

Citations per year, relative to James Miller James Miller (= 1×) peers Shiro Matsubara

Countries citing papers authored by James Miller

Since Specialization

Citations

This map shows the geographic impact of James Miller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Miller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Miller more than expected).

Fields of papers citing papers by James Miller

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Miller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Miller. The network helps show where James Miller may publish in the future.

Co-authorship network of co-authors of James Miller

This figure shows the co-authorship network connecting the top 25 collaborators of James Miller. A scholar is included among the top collaborators of James Miller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Miller. James Miller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Burke, Georgina, Maria Elena Farrugia, Pablo Garcia-Reitboeck, et al.. (2025). Efgartigimod efficacy and safety in refractory myasthenia gravis: UK’s first real-world experience. Journal of Neurology Neurosurgery & Psychiatry. 96(4). 322–328. 4 indexed citations

Dodd, Katherine, Fiona J. Clay, J. Handley, et al.. (2025). Rituximab for myasthenia gravis. Cochrane Database of Systematic Reviews. 2025(7). CD014574–CD014574. 1 indexed citations

Dodd, Katherine, James Holt, Saiju Jacob, et al.. (2024). Mycophenolate and methotrexate are better tolerated than azathioprine in myasthenia gravis. Neuromuscular Disorders. 38. 51–57. 2 indexed citations

Morrow, Jasper M., et al.. (2023). Two emerging phenotypes of atypical inclusion body myositis: illustrative cases. Clinical and Experimental Rheumatology. 41(2). 340–347. 7 indexed citations

Dodd, Katherine, Fiona J. Clay, Ryan Keh, et al.. (2023). Rituximab for myasthenia gravis. Cochrane Database of Systematic Reviews. 2023(4). 3 indexed citations

Anderson, Kirstie N., et al.. (2022). Delivering an advice and guidance service in neurology. Practical Neurology. 22(3). 209–212. 2 indexed citations

Lunn, Daniel, Iwona Skorupinska, Louise Germain, et al.. (2021). Longitudinal observational study investigating outcome measures for clinical trials in inclusion body myositis. Journal of Neurology Neurosurgery & Psychiatry. 92(8). 854–862. 24 indexed citations

Jones, Katherine, Fiona Hawke, Jane Newman, et al.. (2021). Interventions for promoting physical activity in people with neuromuscular disease. Cochrane Database of Systematic Reviews. 2021(7). CD013544–CD013544. 11 indexed citations

Jones, Katherine, Fiona Hawke, Jane Newman, et al.. (2020). Interventions for promoting physical activity in people with neuromuscular disease. Cochrane Database of Systematic Reviews. 8 indexed citations

10.

Berg, Bianca van den, David R. Cornblath, Esmée Venema, et al.. (2019). Original research: Second IVIg course in Guillain-Barré syndrome with poor prognosis: the non-randomised ISID study. Journal of Neurology Neurosurgery & Psychiatry. 91(2). 113–121. 33 indexed citations

11.

Bánsági, Boglárka, Mark R. Baker, Julia O’Sullivan, et al.. (2018). Multifocal demyelinating motor neuropathy and hamartoma syndrome associated with a de novo PTEN mutation. Neurology. 90(21). e1842–e1848. 5 indexed citations

12.

Rygiel, Karolina A., Helen Tuppen, John P. Grady, et al.. (2016). Complex mitochondrial DNA rearrangements in individual cells from patients with sporadic inclusion body myositis. Nucleic Acids Research. 44(11). 5313–5329. 33 indexed citations

13.

Rose, Michael R., Katherine Jones, Kevin Leong, et al.. (2015). Treatment for inclusion body myositis. Cochrane Database of Systematic Reviews. 2015(7). CD001555–CD001555. 21 indexed citations

14.

Wesołowska, Maria, Gráinne S. Gorman, Charlotte L. Alston, et al.. (2015). Adult Onset Leigh Syndrome in the Intensive Care Setting: A Novel Presentation of a C12orf65 Related Mitochondrial Disease. Journal of Neuromuscular Diseases. 2(4). 409–419. 19 indexed citations

15.

Cruz, Pedro M. Rodríguez, Yue‐Bei Luo, James Miller, et al.. (2014). An analysis of the sensitivity and specificity of MHC-I and MHC-II immunohistochemical staining in muscle biopsies for the diagnosis of inflammatory myopathies. Neuromuscular Disorders. 24(12). 1025–1035. 54 indexed citations

16.

Miller, James, et al.. (2014). Anti-GQ1b ganglioside positive Miller Fisher syndrome – evidence of paranodal pathology on nerve biopsy. Journal of Neuromuscular Diseases. 1(2). 191–195. 11 indexed citations

17.

Pfeffer, Gerald, Hannah R. Elliott, Helen Griffin, et al.. (2012). Titin mutation segregates with hereditary myopathy with early respiratory failure. Brain. 135(6). 1695–1713. 88 indexed citations

18.

Matthews, Emma, James Miller, Malcolm Macleod, et al.. (2011). Sodium and chloride channelopathies with myositis: Coincidence or connection?. Muscle & Nerve. 44(2). 283–288. 2 indexed citations

19.

Mastaglia, Frank, Patricia Price, Susan Walters, et al.. (2006). Familial inclusion body myositis in a mother and son with different ancestral MHC haplotypes. Neuromuscular Disorders. 16(11). 754–758. 12 indexed citations

20.

Miller, James. (2005). Statins – challenges and provocations. Current Opinion in Neurology. 18(5). 494–496. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact